Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2026-04-06
Integer Announces Board Leadership TransitionITGR — Integer Holdings Corp
NYSE · Health Care · Health Care
$86.02+16.04%Market cap2.99B
- Latest Close
- $86.02
- 30-Day Move
- +16.0%
- Market Cap
- $3.0B
- Shares Outstanding
- 34,410,000
- P/E Ratio
- 29.07
- P/B Ratio
- 1.57
Analyst consensus: Buy · 17 analysts
NYSE:ITGRHealth Care / Health CareDelayed public snapshot
Integer Holdings Corp
A read-only Alphactor snapshot forInteger Holdings Corp. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-24
Topline snapshot
Latest Close
$86.02
30-Day Move
+16.0%
Market Cap
$3.0B
Shares Outstanding
34,410,000
P/E Ratio
29.07
P/B Ratio
1.57
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$86.02
+16.0%last 90 delayed daily bars
Market cap$3.0B
90D High
$100.05
90D Low
$73.15
Avg Volume
716,884
What stands out
Gross margin is running at 27.4%, which gives a quick read on operating quality before you open the full model.
Net margin is 5.5%, useful for comparing ITGR against peers in Health Care.
ITGR is up 16.0% over the last 30 trading days shown on this page.
Latest operating income is $55M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$92.74
Rule of 40
13.7%
Fundamentals snapshot
Latest Close
$86.02
30-Day Move
+16.0%
Market Cap
$3.0B
Shares Outstanding
34,410,000
P/E Ratio
29.07
P/B Ratio
1.57
ROE
5.9%
ROA
3.0%
Gross Margin
27.4%
Operating Margin
11.9%
Net Margin
5.5%
Debt / Equity
0.7
Current Ratio
3.32
Latest Revenue
$472M
Financial statement snapshot
Revenue
$472M
Gross Profit
$125M
Operating Income
$55M
Net Income
$49M
Gross Margin
2739.0%
Net Margin
555.0%
Current Ratio
3.32
Debt / Equity
0.70
Valuation snapshot
Fair Value
$92.74
Upside / Downside
+7.8%
Signal
Fairly Valued
Implied Growth
15.8%
DCF
$29.11
EPV
$17.42
EV/Rev
$231.70
Growth Assumption
11.7%
Discount Rate
9.0%
Terminal Growth
2.0%
Base FCF
$105M
Valuation spread
Current Price
$86.02
Composite Fair Value
$92.74
DCF
$29.11
EPV
$17.42
EV/Rev
$231.70
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Moderate growth priced in
Quality snapshot
Altman Z
2.45
Grey
Piotroski
6
Moderate (4-6)
Cash Conversion
1.91x
Rule of 40
13.7%
Concerning
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $1.3B | $128M | $66M | $42M |
| 2023-12-31 | $1.6B | $175M | $91M | $60M |
| 2024-12-31 | $1.7B | $220M | $120M | $100M |
| 2025-12-31 | $1.9B | $239M | $103M | $105M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/themotleyfool.ico', homepage_url='https://www.fool.com/', logo_url='https://s3.massive.com/public/assets/news/logos/themotleyfool.svg', name='The Motley Fool')•2026-03-24
Integer Stock Down 28% as Insider Reports Sale. Here's What to KnowPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2026-03-20
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your BehalfPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2026-03-18
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your BehalfPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2026-03-12
Integer Appoints James Flanagan and Aaron Kapito to Board of DirectorsAfter signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$0
Sell Value
$70,125
Buys
0
Sells
1
Buy Value
$0
Sell Value
$70,125
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | Harris John A | M | 3,837 | $0.00 |
| 2026-03-31 | Harris John A | F | 1,842 | $88.00 |
| 2026-03-31 | Harris John A | M | 3,837 | $0.00 |
| 2026-03-24 | Carr Terence | M | 1,350 | $0.00 |
| 2026-03-24 | Carr Terence | F | 398 | $86.19 |
| 2026-03-24 | Carr Terence | M | 1,350 | $0.00 |
| 2026-03-24 | Blackwood Lindsay K. | M | 1,706 | $0.00 |
| 2026-03-24 | Blackwood Lindsay K. | M | 1,777 | $0.00 |
Institutional holders snapshot
BlackRock
Filed 2024-05-10
$628M
--
Vanguard Group
Filed 2025-08-11
$481M
+3.6%
Invesco
Filed 2025-08-13
$196M
+4.1%
Capital Research Global Investors
Filed 2025-05-12
$164M
--
Geode Capital Management
Filed 2025-08-08
$101M
+3.9%
Analyst consensus?
Rating(?)
3.71
Consensus
BuyTarget Mean(?)
—
Target High(?)
—
Target Low(?)
—
Analysts
17
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.